158 related articles for article (PubMed ID: 32966885)
1. Targeted Next-Generation Sequencing and Allele-Specific Quantitative PCR of Laser Capture Microdissected Samples Uncover Molecular Differences in Mixed Odontogenic Tumors.
Coura BP; Bernardes VF; de Sousa SF; Diniz MG; Moreira RG; de Andrade BAB; Romañach MJ; Pontes HAR; Gomez RS; Odell EW; Gomes CC
J Mol Diagn; 2020 Dec; 22(12):1393-1399. PubMed ID: 32966885
[TBL] [Abstract][Full Text] [Related]
2. Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors.
Sousa SF; Gomez RS; Diniz MG; Bernardes VF; Soares FF; Brito JA; Liu S; Pontes HA; Stratakis CA; Gomes CC
Endocr Relat Cancer; 2015 Jun; 22(3):399-408. PubMed ID: 25870248
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of odontogenic cysts and tumours.
Gomes IP; Bastos VC; Guimarães LM; Gomes CC
J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity (LOH) in tumour suppressor genes in benign and malignant mixed odontogenic tumours.
Galvão CF; Gomes CC; Diniz MG; Vargas PA; de Paula AM; Mosqueda-Taylor A; Loyola AM; Gomez RS
J Oral Pathol Med; 2012 May; 41(5):389-93. PubMed ID: 22082131
[TBL] [Abstract][Full Text] [Related]
5. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
[TBL] [Abstract][Full Text] [Related]
6. Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations.
Agaimy A; Skalova A; Franchi A; Alshagroud R; Gill AJ; Stoehr R; Baumhoer D; Bauer S
Histopathology; 2020 May; 76(6):814-821. PubMed ID: 31899815
[TBL] [Abstract][Full Text] [Related]
7. Frequent oncogenic BRAF V600E mutation in odontogenic keratocyst.
Cha YH; Cho ES; Kang HE; Ko J; Nam W; Kim HJ; Kim NH; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Nov; 74():62-67. PubMed ID: 29103753
[TBL] [Abstract][Full Text] [Related]
8. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
[TBL] [Abstract][Full Text] [Related]
9. Mixed odontogenic tumors in four young dogs: ameloblastic fibroma and ameloblastic fibro-odontoma.
Huang P; Bell C; Wallace V; Murphy BG
J Vet Diagn Invest; 2019 Jan; 31(1):98-102. PubMed ID: 30451090
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of BRAF p.V600E and Detection Methods in Benign Mixed and Malignant Odontogenic Tumors: A Systematic Review.
Severino-Lazo RJG; de Vasconcelos Carvalho M; Campello CP; Moraes SLD; do Egito Vasconcelos BC; Pellizzer EP
Head Neck Pathol; 2023 Dec; 17(4):1000-1010. PubMed ID: 38057461
[TBL] [Abstract][Full Text] [Related]
11. Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis.
Togni L; Zizzi A; Mazzucchelli R; Santarelli A; Rubini C; Mascitti M
Int J Oral Sci; 2022 Apr; 14(1):22. PubMed ID: 35468886
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing of oncogenes and tumor suppressor genes in odontogenic myxomas.
Santos JN; Sousa Neto ES; França JA; Diniz MG; Moreira RG; Castro WH; Gomez RS; de Sousa SF; Gomes CC
J Oral Pathol Med; 2017 Nov; 46(10):1036-1039. PubMed ID: 28597929
[TBL] [Abstract][Full Text] [Related]
13. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
[No Abstract] [Full Text] [Related]
14. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
[TBL] [Abstract][Full Text] [Related]
15. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
[TBL] [Abstract][Full Text] [Related]
16. The expression and immunohistochemical localization of periostin in odontogenic tumors of mixed epithelial/mesenchymal origin.
Chau E; Daley T; Darling MR; Hamilton D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):214-20. PubMed ID: 23849375
[TBL] [Abstract][Full Text] [Related]
17. Connexin 43 expression in tooth germ and benign odontogenic tumors.
Silveira FM; Molina-Frechero N; López-Verdín S; Umpiérrez NG; Palacio-Gastellum MG; Almeda-Ojeda O; González-González R; Martins MD; Sicco E; Pereira-Prado V; Bologna-Molina R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 May; 135(5):661-668. PubMed ID: 36925450
[TBL] [Abstract][Full Text] [Related]
18. [BRAF gene mutations in ameloblastic fibromas].
You Z; Xu LL; Li XF; Zhang JY; DU J; Sun LS
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):4-8. PubMed ID: 30773536
[TBL] [Abstract][Full Text] [Related]
19. Assessment of BRAF
Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
[TBL] [Abstract][Full Text] [Related]
20. The importance of BRAF-V600E mutation to ameloblastoma metabolism.
Duarte-Andrade FF; Silva AMB; Vitório JG; Canuto GAB; Costa SFS; Diniz MG; Fernandes AP; de Toledo JS; André LC; Gomes CC; Gomez RS; Fonseca FP
J Oral Pathol Med; 2019 Apr; 48(4):307-314. PubMed ID: 30739334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
